Filing Details

Accession Number:
0001209191-15-064675
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-07 17:08:15
Reporting Period:
2015-08-06
Filing Date:
2015-08-07
Accepted Time:
2015-08-07 17:08:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
860730 Hca Holdings Inc. HCA Services-General Medical & Surgical Hospitals, Nec (8062) 273865930
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216856 A Robert Waterman One Park Plaza
Nashville TN 37203
Svp & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-06 60,429 $5.31 552,748 No 4 M Direct
Common Stock Acquisiton 2015-08-06 149,175 $11.32 701,923 No 4 M Direct
Common Stock Disposition 2015-08-06 145,302 $91.23 556,621 No 4 S Direct
Common Stock Disposition 2015-08-06 49,803 $92.23 506,818 No 4 S Direct
Common Stock Disposition 2015-08-06 14,499 $92.82 492,319 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-08-06 60,006 $0.00 60,006 $5.31
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-08-06 423 $0.00 423 $5.31
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-08-06 90,009 $0.00 90,009 $11.32
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-08-06 59,166 $0.00 59,166 $11.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-01-30 No 4 M Direct
59,588 2017-01-30 No 4 M Direct
0 2017-01-30 No 4 M Direct
0 2017-01-30 No 4 M Direct
Footnotes
  1. The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2015.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.745 to $92.72, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.74 to $93.04, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
  6. The option vested in equal increments at the end of fiscal years 2010 and 2011 based upon the achievement of certain annual EBITDA performance targets.
  7. Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
  8. The option vested in two equal annual installments beginning on January 30, 2011.
  9. The option vested in three equal annual installments beginning on January 30, 2008.
  10. The option vested in equal increments at the end of fiscal years 2007, 2008, and 2009 based upon the achievement of certain annual EBITDA performance targets.